AT360622T - Substituted 2-aryl-4-amino-chinazolines, method for the production thereof and their use as medicaments - Google Patents

Substituted 2-aryl-4-amino-chinazolines, method for the production thereof and their use as medicaments

Info

Publication number
AT360622T
AT360622T AT98966301T AT98966301T AT360622T AT 360622 T AT360622 T AT 360622T AT 98966301 T AT98966301 T AT 98966301T AT 98966301 T AT98966301 T AT 98966301T AT 360622 T AT360622 T AT 360622T
Authority
AT
Austria
Prior art keywords
chinazolines
medicaments
aryl
amino
substituted
Prior art date
Application number
AT98966301T
Other languages
German (de)
Inventor
Ursula Schindler
Peter Schindler
Karl Schoenafinger
Hartmut Strobel
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE19756388A priority Critical patent/DE19756388A1/en
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of AT360622T publication Critical patent/AT360622T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
AT98966301T 1997-12-18 1998-12-11 Substituted 2-aryl-4-amino-chinazolines, method for the production thereof and their use as medicaments AT360622T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19756388A DE19756388A1 (en) 1997-12-18 1997-12-18 New 2-aryl-4-amino-6,7-di:methoxy-quinazoline derivatives useful as guanylate cyclase activators for treating cardiovascular diseases, etc.

Publications (1)

Publication Number Publication Date
AT360622T true AT360622T (en) 2007-05-15

Family

ID=7852434

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98966301T AT360622T (en) 1997-12-18 1998-12-11 Substituted 2-aryl-4-amino-chinazolines, method for the production thereof and their use as medicaments

Country Status (9)

Country Link
US (1) US6613772B1 (en)
EP (1) EP1040101B1 (en)
JP (1) JP4436965B2 (en)
AT (1) AT360622T (en)
AU (1) AU2270899A (en)
CA (1) CA2315205C (en)
DE (2) DE19756388A1 (en)
ES (1) ES2285798T3 (en)
WO (1) WO1999032460A1 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836697A1 (en) * 1998-08-13 2000-02-17 Hoechst Marion Roussel De Gmbh New substituted 4-amino-2-aryl-pyrimidines, are soluble guanylate cyclase activators useful e.g. for treating atherosclerosis, hypertension, angina pectoris, thrombosis, asthma or diabetes
US6184226B1 (en) * 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
CA2389773A1 (en) * 1999-11-05 2001-05-10 Robert Glen Activators of soluble guanylate cyclase
EP1110552A1 (en) * 1999-12-22 2001-06-27 Aventis Pharma S.A. Use of a compound with affinity for the mitochondrial benzodiazepine receptor in cancer therapy
AU9091201A (en) 2000-09-15 2002-03-26 Vertex Pharma Pyrazole compounds useful as protein kinase inhibitors
MXPA03002410A (en) * 2000-09-20 2003-06-19 Merck Patent Gmbh 4-amino-quinazolines.
WO2002062767A1 (en) * 2001-02-07 2002-08-15 Sumitomo Pharmaceuticals Company, Limited Novel quinazoline derivatives
AU2003255482A1 (en) * 2002-10-02 2004-04-23 Merck Patent Gmbh Use of 4 amino-quinazolines as anti cancer agents
EP1571146A4 (en) * 2002-12-10 2010-09-01 Ono Pharmaceutical Co Nitrogen-containing heterocyclic compounds and medicinal use thereof
CL2004000409A1 (en) * 2003-03-03 2005-01-07 Vertex Pharma 2- (substituted cyclo) -1- (substituted amino or oxy) -quinazoline derivative compounds, voltage-gated calcium and sodium ion channel inhibitors; pharmaceutical composition; and use of the compound in the treatment of acute, chronic, neu
US7713983B2 (en) * 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
EP1622914B1 (en) * 2003-03-31 2011-06-01 Trovis Pharmaceuticals LLC New piperidinylamino-thieno[2,3-d] pyrimidine compounds
EP1635846A4 (en) * 2003-06-20 2009-01-28 Coley Pharm Gmbh Small molecule toll-like receptor (tlr) antagonists
US7928107B2 (en) * 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US8283354B2 (en) 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US7718658B2 (en) 2004-09-02 2010-05-18 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
WO2006045010A2 (en) 2004-10-20 2006-04-27 Resverlogix Corp. Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
ZA200704972B (en) * 2004-12-17 2008-09-25 Vertex Pharma Processes for producing 4-aminoquinazolines
KR20060079121A (en) * 2004-12-31 2006-07-05 (주) 리드제넥스 Quinazoline derivatives for the treatment or prevention of diabetes and obesity
US8071768B2 (en) * 2005-06-10 2011-12-06 Janssen Pharmaceutica, N.V. Alkylquinoline and alkylquinazoline kinase modulators
US7825244B2 (en) * 2005-06-10 2010-11-02 Janssen Pharmaceutica Nv Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis
WO2007016525A2 (en) 2005-07-29 2007-02-08 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
JP5236664B2 (en) 2007-02-01 2013-07-17 レスバーロジックス コーポレイション Compounds for preventing and treating cardiovascular disease
CA2711103C (en) 2008-06-26 2016-08-09 Resverlogix Corp. Methods of preparing quinazolinone derivatives
EP2373317B1 (en) * 2008-11-25 2016-12-14 Merck Sharp & Dohme Corp. 4-amino-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one or 4-amino-5,8-dihydropyrido[2,3-d]pyrimidin-7(6H)-one derivatives as activators of the soluble guanylat cyclase for the treatment of cardiovascular diseases
EP2382194B1 (en) 2009-01-08 2014-03-12 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
KR101841003B1 (en) 2009-03-18 2018-03-22 리스버로직스 코퍼레이션 Novel anti-inflammatory agents
EP3431086B1 (en) 2009-04-22 2020-06-17 Resverlogix Corp. Novel anti-inflammatory agents
JP2013505909A (en) 2009-09-24 2013-02-21 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Aminoquinazoline compounds for combating invertebrate pests
EP2549875B1 (en) 2010-03-25 2015-05-13 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators
WO2011149921A1 (en) 2010-05-27 2011-12-01 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators
US8440662B2 (en) 2010-10-31 2013-05-14 Endo Pharmaceuticals, Inc. Substituted quinazoline and pyrido-pyrimidine derivatives
CN103945848B (en) 2011-11-01 2016-09-07 雷斯韦洛吉克斯公司 The oral immediate release formulations of the quinazolinone being replaced
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
AU2013365926B9 (en) 2012-12-21 2019-01-17 Zenith Epigenetics Ltd. Novel heterocyclic compounds as bromodomain inhibitors
KR20170117024A (en) * 2014-12-05 2017-10-20 서브라마니암 아난탄 Novel quinazolines as biogenic amine transport modulators
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
WO2020055504A1 (en) * 2018-09-13 2020-03-19 University Of Southern California Novel inhibitors of guanosine monophosphate synthetase as therapeutic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1199768A (en) * 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
GB1390014A (en) * 1971-05-07 1975-04-09 Koninklijke Pharma Fab Nv Process for the preparation of carbocyclic fused pyrimidine derivatives
US3819628A (en) 1972-07-31 1974-06-25 Sandoz Ag 2-phenyl-4-substituted amino-quinazolines and nitrates thereof
JP2657760B2 (en) * 1992-07-15 1997-09-24 小野薬品工業株式会社 4-aminoquinazoline derivatives and pharmaceuticals containing them
AU664337B2 (en) * 1993-06-17 1995-11-09 Otsuka Pharmaceutical Factory, Inc. Phosphonic diester derivative

Also Published As

Publication number Publication date
DE59813983D1 (en) 2007-06-06
CA2315205C (en) 2010-02-02
EP1040101B1 (en) 2007-04-25
JP4436965B2 (en) 2010-03-24
ES2285798T3 (en) 2007-11-16
WO1999032460A1 (en) 1999-07-01
DE19756388A1 (en) 1999-06-24
JP2001526273A (en) 2001-12-18
CA2315205A1 (en) 1999-07-01
US6613772B1 (en) 2003-09-02
EP1040101A1 (en) 2000-10-04
AU2270899A (en) 1999-07-12

Similar Documents

Publication Publication Date Title
RU96102154A (en) New pharmaceutical composition, method for its production, method for treating diseases using the composition
FR2783246B1 (en) Azetidine derivatives, their preparation and the medicines containing them
DK0946546T3 (en) Pyridin-2-yl-methylamine derivatives, process for their preparation and use as pharmaceuticals
AT449841T (en) Micronadel devices and method for the production thereof
AT125255T (en) Decahydroisoquinoline derivatives, method for the production thereof and their use as medicines.
AT379971T (en) Disinfection agents and method for the production thereof
AT126219T (en) Benzimidazole derivatives, method for the production and use thereof.
IL146105A (en) 5-pyridyl-1, 3-azole compounds, process for producing the same and use therefor
RU96101139A (en) New erythromycin derivatives, method for their production and use as medicines
AT328006T (en) New protein and method for the production thereof
AT253830T (en) Stored finished done and method for the production thereof
HU0004422A3 (en) 2-aryl-8-oxohydropurine derivatives, process for producing them, medicaments containing the same
AT339921T (en) For unique use, specific rasples, in particular bone raspes, and method for the production thereof
AT159271T (en) Redispergable, silicon-modified dispersion powder composition, method for the production and use thereof
HRP980082A2 (en) Disubstituted bicyclic heterocycles, their production and use as medicaments
AT537176T (en) Rapamycin hydroxyesteres, process for the production thereof and pharmaceutical compositions containing them
DE69929311D1 (en) Oximanderivates and method for the production thereof
AT301624T (en) Method for producing substituted indanoes, the substituted indanoes and metallocene produced thereof
AT471924T (en) 3-alkyl-5,5 ', 6,6', 7,7 ', 8,8'-octahydro-2,2'-binaphthole and 3,3'-dialkyl-5,5', 6,6 ', 7,7 ', 8,8'-octahydro-2,2'-binaphthole, and method for the production thereof
AT261934T (en) Substituted aryl and heteroarylamidine derivatives, their production and their use as medicinal products
AT204269T (en) Substituted biphenyl or phenylpyridine derivatives, method for the production thereof and pharmaceutical compositions containing the same
AT128458T (en) Naphtylalkylamine, method for the production thereof and pharmaceutical compositions containing the same.
AT312105T (en) Camptothecinanaloges, method for the production thereof, their use as a medicament and the pharmaceutical compositions containing thereof
AT270685T (en) Polyammonium-polysiloxane compounds, method for the production thereof and their use
RU2001131111A (en) New compounds, their production and application

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee